Table 4.
Medications used throughout the disease course
| Monocyclic (n=29) | % | Polycyclic (n=7) | % | Chronic persistent (n=12) | % |
|---|---|---|---|---|---|
| Corticosteroids (oral) | 96.5 | Corticosteroids (oral) | 100 | Corticosteroids (oral) | 100 |
| Corticosteroids (pulse) | 68.9 | Corticosteroids (pulse) | 100 | Corticosteroids (pulse) | 91.6 |
| Methotrexate | 93.1 | Methotrexate | 100 | Methotrexate | 100 |
| HCQ | 20.6 | HCQ | 42.8 | HCQ | 33.3 |
| IVIG | 13.7 | IVIG | 71.4 | IVIG | 83.3 |
| MMF | 3.4 | MMF | 14.2 | MMF | 66.6 |
| Cyclosporine | 28.5 | Cyclosporine | 16.6 | ||
| Cyclophosphamide | 25 | ||||
| Rituximab | 25 | ||||
| Pamidronate | 25 | ||||
| Infliximab | 16.6 | ||||
| Tofacitinib | 16.6 | ||||
| Etanercept | 8.3 |
HCQ: Hydroxychloroquine; IVIG: Intravenous immunoglobulin; MMF: Mycophenolate mofetil.